Skip to main content
Eligibility
for males ages 50 years and up
Dates
study started
estimated completion:
Principal Investigator

Description

Summary

The purpose of this study is to determine whether psilocybin-assisted group psychotherapy is a safe and feasible treatment for demoralization in long-term AIDS survivors (LTAS).

Details

This study is an open-label mixed-methods pilot study of an individual oral psilocybin drug session combined with eight sessions of an evidence-based, manualized brief group psychotherapy for existential distress in palliative care patients. This study aims to include at least two therapy groups of at least four members each.

Keywords

Distress Depression Grief HIV/AIDS Demoralization Psilocybin Group therapy Psilocybine N,N-Dimethyltryptamine

Eligibility

For males ages 50 years and up

Inclusion Criterion:

  • Older gay-identified men who are long-term AIDS survivors and suffer from moderate-to-severe demoralization.

Exclusion Criteria:

  • A physical, neurological or cognitive condition that makes participating in the study unsafe or unfeasible.
  • Regular psychotropic medication use.
  • Personal or family history of serious mental illness.
  • Severe depression requiring immediate standard-of-care treatment.
  • Current substance use disorder (other than tobacco).
  • Exclusion by the clinical judgment of the study investigators.

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
Joshua Woolley
ID
NCT02950467
Phase
Phase 1
Lead Scientist
Joshua Woolley
Study Type
Interventional
Last Updated
November 1, 2016
I'm interested in this study!